1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
LOI due January 14, 2026 (5pm); Full application due March 11, 2026. LOI decision notifications sent February 6, 2026.
"Harold Hamm Diabetes Center Grant Opportunities (I2 Accelerator, Team Science, Novel Pilot, Bridge Funding, Equipment Grants)" is currently closed and not accepting applications.
Harold Hamm Diabetes Center Grant Opportunities (I2 Accelerator, Team Science, Novel Pilot, Bridge Funding, Equipment Grants) is sponsored by Harold Hamm Diabetes Center (OU Health). The Harold Hamm Diabetes Center offers various pilot funding opportunities to its members for diabetes research and closely related cardiometabolic conditions like obesity, liver disease, and cancer.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Grant Opportunities | Harold Hamm Diabetes Center Harold Hamm Diabetes Center Diabetes Research Harold Hamm Diabetes Center Grant Opp ... Harold Hamm Diabetes Center Grant Opportunities Opportunities for Harold Hamm Diabetes Center members include funding awards core facilities . Several types of funding awards are available to members to support the development of their work.
Award applications are evaluated on a competitive, peer-reviewed basis by the Harold Hamm Research Grants Committee and External Review Panel. Additional awards, such as matching awards to other funding opportunities, will be announced if they become available. Funding Opportunity Summary The Harold Hamm Diabetes Center (HHDC) is pleased to announce pilot funding opportunities for 2026.
The HHDC Pilot Program will consider funding for the following types of funding: I2 Accelerator, Team Science, Novel Pilot (Faculty and Post-Doc tracks), Bridge Funding, and Equipment Grants. Based on a matching gift, the HHDC will award up to $2. 5M to researchers to launch investigations for diabetes research.
For projects that feature collaboration between researchers of Diabetes and Cancer, the Stephenson Cancer Center has the potential to augment funding.
I2 Accelerator Grant: $300,000 for up to 2 years Team Science Grant: $100,000 per year for up to 3 years Novel Pilot Grant (Faculty and Post-Doc tracks): $70,000 per year for up Bridge Grant: $100,000 for 1 year Equipment Grant: Up to $250,000 HHDC-SCC Funded Programs: Team Science Grant: $100,000 per year for up to 3 years Novel Pilot Grant (Faculty or Post-Doc tracks): $70,000 per year for up Applications should be closely aligned with the mission of the HHDC to increase understanding about the causes and consequences of diabetes and closely related cardiometabolic conditions like obesity, liver disease, and cancer (HHDC-SCC proposals), as well as strategies for prevention or treatment of these conditions.
The goal of all HHDC funding projects should be to support the development of successful extramural grants from the NIH (e.g. NIDDK grants will be given priority), American Diabetes Association, Breakthrough T1D, etc. Proposals that address one or more of the following themes are HHDC funding Theme 1: Diabetes and Obesity, origins within the first 1000 days of life or changes across the lifespan.
These are proposals that aim to gain basic science and clinical knowledge on the inter-relationship of obesity and diabetes during fetal development and early life, or across the lifespan.
For example, we are interested in studies of the genetic, epigenetic, and environmental basis of susceptibility to developing insulin resistance, metabolic dysregulation, inflammation, macrovascular and microvascular diabetic complications, obesity, and diabetes. This includes studies of type 1, type 2, and gestational diabetes, and Theme 2: Complications from diabetes and related metabolic disease.
Proposals in this area examine how diabetes, obesity, or complications thereof result in increased morbidity and mortality. Translational research focused on basic mechanisms of disease in pre-clinical models of obesity/diabetes Theme 3: Clinical Research/Public Health.
We seek proposals to investigate new treatments, interventions, and technology for diabetes management, along with strategies to raise awareness, promote prevention, or improve diabetes care. Proposals that address health disparities related to diabetes, and early-stage clinical investigators are particularly Theme 4: Diabetes/Obesity and Cancer.
Proposals in this area examine how diabetes or obesity affect the risk or treatment of cancer. Proposals may include basic and/or clinical models. Team science and novel pilot projects in this area are jointly supported by HHDC and Stephenson Cancer Center.
The emphasis of the HHDC pilot program is to provide foundational support that will permit investigators to compete successfully for extramural sources of research support such as the NIH, American Diabetes Association, JDRF, etc. Projects without evidence of potential for generating external funding will be given lower priority scores during evaluation.
The PI and/or MPI of any HHDC grant application must be an active HHDC Member or Associate Member at the time the Letter of Intent is submitted. The Co-Investigators do not have to be members at the time of application, but if successful are encouraged to become Members or Associate Members of the HHDC during the tenure of the grant.
Active HHDC PIs/MPIs may not apply as PI/MPI for a new Novel, Bridge, I2 Accelerator, or Team Science Grant. The PI/MPI of new grant proposals may maintain roles as Co-Investigators (Co-Is) on active HHDC-supported grants. Letters of Intent are due to 5 p.
m. on Wednesday, Jan. 14, 2026.
Applicants with LOI proposals that fit the HHDC mission and have potential for success will be invited to submit a full application in March. All LOI applicants will be notified about the status of their proposal by Please see the templates below for grant-specific submission requirements. Application requirements and attachments will vary by proposal type.
Please see grant specific guidelines below for further information. In accordance with OUHSC policy, a SoonerTrack routing form should be submitted at least three to five full business days prior to the March 11, 2026 grant application deadline . Applicants are expected to work with their assigned Sponsored Program Administrator (SPA) for review of the application.
Once the review is complete, the Face Page of the application must be signed by the ORA Official (or equivalent signing official at institutions other than OUHSC) before the PI submits the final application to HHDC. Please note: HHDC will e-mail PIs with projects eligible for second- or third-year renewals with details on renewal application processes.
For questions, please reach out directly to Review of Final Application The HHDC Grants Review Committee will review and award grants in consultation with two outside reviewers and one internal reviewer. Outside reviewers will be selected for each application based on their relevant subject matter expertise.
Once appointed, the HHDC Grants Review Committee and panel of outside reviewers will evaluate the proposal to come to a funding decision. Program Application and Deadlines All applications will follow the HHDC Application Form, Terms and Guidelines *Please note that the Pilot Grant RFA/guidelines have been updated for 2026. Please refer to the guidelines below for the most current version.
HHDC Pilot Grant Guidelines: (Grants with the potential for SCC collaborative funding denoted by “*”) Novel Pilot Project Grant * Additional HHDC funding opportunity guidelines: Coming in Spring of 2026 – SEED grant opportunity For questions or for special exception of the announcement approval, please contact Explore Supportive Care services for your cancer journey Find out if you’re at risk for diabetes See what our commitment to ending diabetes in this century means for you Find out how geroscience research at OU Health is driving the future of health Explore related programs at the University of Oklahoma Health Sciences Center View All OU Health Services Diabetes & Endocrinology, Internal Medicine Pediatric Diabetes & Endocrinology, Diabetes & Endocrinology Kacy Aderhold, APRN,BC-ADM,CDCES Mary Dianne Brown, MS,CDCES,RDN,LD OU Health Harold Hamm Diabetes Center — Adult Diabetes & Endocrinology 1000 N.
Lincoln Blvd. , Suite 3400 Schusterman Center — OU Health Harold Hamm Diabetes & Endocrinology Clinic Harold Hamm Diabetes Center Spring 2026 Newsletter Spring 2026 Newsletter This Spring issue highlights: Director's Corner Groundbreaking of New Diabetes Research Space in BSEB, Connect+Cure ...
Harold Hamm Diabetes Center Spring 2026 Newsletter Spring 2026 Newsletter This Spring issue highlights: Director's Corner Groundbreaking of New Diabetes Research Space in BSEB, Connect+Cure Gala, and ... Gala Raises $4. 7 Million for OU Health Harold Hamm Diabetes Center More than 800 people attended the 2025 Connect+Cure Gala on Wednesday night, raising $4.
7 million to support research and programs at the OU Health ... Harold Hamm Diabetes Center Fall 2025 Newsletter Fall 2025 Newsletter This Fall issue highlights: Director's Corner Harold Hamm Diabetes Center Pilot Awards top $1. 2 Million Laureate Announced for ...
Scoring criteria used to review proposals for this grant.
According to the current listing, eligibility includes: Must be an active HHDC Member or Associate Member at time of LOI submission. Active PIs cannot reapply as PI/MPI but may serve as Co-Investigators. Confirm the full requirements in the official notice before applying.
The current listing shows varies by grant type (e.g., I2 Accelerator: $300,000 for up to 2 years; Team Science: $100,000 per year for up to 3 years). Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was March 11, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Harold Hamm Diabetes Center Grant Opportunities (I2 Accelerator, Team Science, Novel Pilot, Bridge Funding, Equipment Grants) is funded by Harold Hamm Diabetes Center (OU Health). Verify program details on the funder's official page before applying.
This opportunity targets applicants in Oklahoma. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The Gates Foundation committed at least $1 billion over two years to equitable AI alongside its 10th Goalkeepers Report — 40% education, 40% health, 10% agriculture, 10% digital infrastructure. Five days later, 60 organizations signed a five-year goal to reach 3.4 billion speakers of underrepresented languages. Here is how implementing nonprofits should read both.
Read articleThe Health and Extreme Weather highlighted topic went live September 1, 2026 with eleven awarding institutes and expires May 1, 2028. There is no set-aside, no separate deadline, and no review criteria — which makes the institute-by-institute language the only real signal, and it is not uniform.
Read articleThe NOURISH Autoimmunity Digital Health Challenge runs three phases to August 2028: 10 winners at $20,000, then 5 at $30,000, then 3 at $100,000. It is a prize competition, not a grant — no indirect costs, no cost reimbursement, and a rule that quietly disqualifies the obvious applicant.
Read article